Goldenwell Biotech, Inc. financial data

Symbol
GWLL on OTC
Industry
Food and Kindred Products
Location
581 Boston Mills Road, Suite 300, Hudson, Ohio
State of incorporation
Nevada
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 20, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Quick Ratio 294 % -27.2%
Debt-to-equity 109 % +480%
Return On Equity -119 % +74.4%
Return On Assets -56.7 % +85.5%
Operating Margin -10.6K % -426%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99M shares 0%
Common Stock, Shares, Outstanding 99M shares 0%
Entity Public Float 12.7M USD 0%
Common Stock, Value, Issued 9.9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 96.4M shares +5.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 47.8K USD +199%
Revenue from Contract with Customer, Excluding Assessed Tax 1.08K USD -97.8%
Cost of Revenue 600 USD -97.4%
General and Administrative Expense 115K USD -88.7%
Operating Income (Loss) -114K USD +88.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -114K USD +88.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46K USD -78.5%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Inventory, Net 175K USD -0.34%
Operating Lease, Right-of-Use Asset 0 USD
Assets 199K USD -9.32%
Accounts Payable, Current 0 USD
Liabilities, Current 29.1K USD -76.9%
Liabilities 145K USD +182%
Retained Earnings (Accumulated Deficit) -1.26M USD -9.99%
Stockholders' Equity Attributable to Parent 53.7K USD -68%
Liabilities and Equity 199K USD -9.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -114K USD +88.1%
Net Cash Provided by (Used in) Financing Activities 2.1K USD -93%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 99M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.2K USD -45%
Deferred Tax Assets, Valuation Allowance 264K USD +9.99%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability, Current 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 25.4K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.6K USD
Deferred Tax Assets, Operating Loss Carryforwards 264K USD +9.99%
Additional Paid in Capital 1.3M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD